CDKN2B anticorps (Cy5)
Aperçu rapide pour CDKN2B anticorps (Cy5) (ABIN706170)
Antigène
Voir toutes CDKN2B AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Specificité
- Excitation / Emission Wavelengths: 650nm/670nm
-
Réactivité croisée
- Rat (Rattus), Poulet, Chien, Boeuf (Vache)
-
Purification
- purified by Protein A
-
Immunogène
- KLH conjugated synthetic peptide derived from human CDKN2B
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
IF(IHC-P)(1:100-500)
Optimal working dilution should be determined by the investigator. -
Commentaires
-
Excitation / Emission wavelength: 652nm / 670nm
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 µg/µL
-
Buffer
- Aqueous buffered solution containing 100 µg/mL BSA, 50 % glycerol and 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
Stockage commentaire
- Store at 4 °C for 12 months
-
Date de péremption
- 12 months
-
-
- CDKN2B (Cyclin-Dependent Kinase Inhibitor 2B (p15, Inhibits CDK4) (CDKN2B))
-
Autre désignation
- CDKN2B
-
Sujet
- P15 INK4b / MTS 2 (Mitotic Inhibitor / Suppressor Protein) is a specific inhibitor of cdk 4 / cdk 6 and is periodically expressed during the cell cycle. Reportedly, p15 INK4b expression is induced approximately 30 fold in human keratinocytes by treatment with TGF beta, suggesting that p15 INK4b may act as an effector of TGF beta mediated cell cycle arrest. p15 INK4b is mapped to chromosome 9p21, a region of frequent loss in a wide variety of cancers.
-
Poids moléculaire
- 15kDa
-
ID gène
- 1030
-
Pathways
- Cycle Cellulaire, Mitotic G1-G1/S Phases
Antigène
-